A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects

NCT02000765 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Respiratory Tract

Interventions

DRUG: GSK2140944 for Injection
DRUG: GSK2140944 Capsule

Sponsor

GlaxoSmithKline